Table 3 HLA-class II allele frequencies of HCV infected subjects

DRB1*01

6.25

14.6

0.37

0.12 – 1.08

0.07

Caucasian

7.58

19.6

0.27

0.13 – 1.00

0.05

DRB1*03

14.3

10.4

1.56

0.63 – 3.86

0.34

DRB1*04

13.4

18.7

0.83

0.35 – 1.98

0.68

DRB1*07

17.0

8.35

2.42

0.95 – 6.23

0.07

DRB1*09

1.60

2.08

0.87

0.12 – 6.24

0.89

DRB1*11

10.7

12.5

0.84

0.34 – 2.09

0.71

DRB1*12

4.46

6.25

0.70

0.20 – 2.46

0.58

DRB1*13

16.1

9.38

1.62

0.64 – 4.12

0.31

DRB1*14

3.70

8.35

0.46

0.12 – 1.68

0.24

DRB1*15

9.82

6.25

1.75

0.60 – 5.15

0.31

DRB1*16

2.67

2.08

1.33

0.21 – 8.31

0.76

DQB1*02

25.9

16.3

1.79

0.91 – 3.54

0.09

Caucasian

34.8

15.2

2.98

1.15 – 7.71

0.02

DQB1*03

28.6

40.8

0.39

0.18 – 0.92

0.02

non-Cauc

23.9

44.2

0.20

0.06 – 0.67

0.01

DQB1*04

5.40

2.10

4.24

0.76 – 23.6

0.10

DQB1*05

10.7

21.4

0.42

0.18 – 1.01

0.05

Caucasian

9.10

23.9

0.23

0.07 – 0.82

0.02

DRB1*06

29.4

19.4

1.72

0.79 – 3.76

0.17